AGGRENOX
AGGRENOX
Discontinued
DIN Number
02242119
Drug Class
Human
Market Date
Apr 17, 2000
Company
HC
boehringer ingelheim (canada) ltd ltee
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02242119
AIG Number0215712003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AC30 COMBINATIONS
Product Specifications
Dosage FormCapsule (Immediate And Extended Release)
Route of AdministrationOral
AHFS Classification24:12.92
Health Canada Classification
ACTIVE INGREDIENTS (2)
ACETYLSALICYLIC ACIDActive
Strength: 25 MG
Monograph: ACETYLSALICYLIC ACID
DIPYRIDAMOLEActive
Strength: 200 MG
Monograph: DIPYRIDAMOLE